International Journal of Laboratory Hematology

(The TQCC of International Journal of Laboratory Hematology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
COVID‐19 and the clinical hematology laboratory174
Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2113
Absolute lymphocyte count is a prognostic marker in Covid‐19: A retrospective cohort review71
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia65
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐257
Evaluation of COVID‐19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays54
Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis49
COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces48
Standardization of Prothrombin Time/International Normalized Ratio (PT/INR)47
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐1942
A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity40
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy40
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID‐19 outbreak: Letter from the warfront…40
COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations35
LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR‐15534
The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays33
Machine learning in health care and laboratory medicine: General overview of supervised learning and Auto‐ML31
COVID‐19–related laboratory coagulation findings28
SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐1927
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS1325
Clinical and hematological characteristics of 88 patients with COVID‐1924
Testing for antiphospholipid antibodies: Advances and best practices24
Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit24
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients24
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID‐19 infection23
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing23
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory22
Peripheral blood morphologic findings in patients with COVID‐1921
A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine21
Lymphopenia in critically ill COVID‐19 patients: A predictor factor of severity and mortality21
Age‐ and sex‐specific pediatric reference intervals for neutrophil‐to‐lymphocyte ratio, lymphocyte‐to‐monocyte ratio, and platelet‐to‐lymphocyte ratio21
Relationship of D‐dimer with severity and mortality in SARS‐CoV‐2 patients : A meta‐analysis21
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting20
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID‐19 patients: Retrospective analysis20
Monocyte volumetric parameters and lymph index are increased in SARS‐CoV‐2 infection20
Higher coagulation activity in hip fracture patients: A case‐control study using rotational thromboelastometry20
Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process19
International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing19
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions19
Neutrophil‐to‐lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID‐1919
Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples19
The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐1918
Clinical assessment of the utility of metagenomic next‐generation sequencing in pediatric patients of hematology department18
COVID‐19 in patients with hematological malignancies: A retrospective case series18
Evaluation of Scopio Labs X100 Full Field PBS: The first high‐resolution full field viewing of peripheral blood specimens combined with artificial intelligence‐based morphological analysis18
Plasmablastic lymphoma: An update18
Kinetics of immune reconstitution after anti‐CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients17
Procoagulant platelets: Laboratory detection and clinical significance17
Gene therapy for hemophilia: Current status and laboratory consequences16
Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection15
Diagnosis and treatment of thrombotic microangiopathy15
How I investigate neutropenia15
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS‐CoV‐2 infection14
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma14
Thrombosis and antiphospholipid antibodies in patients with SARS‐COV‐2 infection (COVID‐19)14
Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway13
Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm13
The hemoglobinopathies, molecular disease mechanisms and diagnostics13
Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa13
Complex biological patterns of hematology parameters in childhood necessitating age‐ and sex‐specific reference intervals for evidence‐based clinical interpretation13
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood13
Peripheral lymphocyte subset alterations in COVID‐19 patients12
P‐glycoprotein and multidrug resistance‐associated protein‐1 expression in acute myeloid leukemia: Biological and prognosis implications12
Lupus anticoagulant in patients with COVID‐1912
Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐1912
The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review12
COVID‐19 and the ABO blood group in pregnancy: A tale of two multiethnic cities12
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab11
Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in NPM1‐mutated acute myeloid leukemia11
International Council for Standardization in Haematology (ICSH) laboratory guidance for the verification of haemostasis analyser‐reagent test systems. Part 2: Specialist tests and calibrated assays11
Flow cytometry in the diagnosis of mature B‐cell lymphoproliferative disorders11
Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban11
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M‐hemoglobin variants11
Analysis of hematological indexes of COVID‐19 patients from fever clinics in Suzhou, China11
Significance of RDW in predicting mortality in COVID‐19—An analysis of 622 cases11
Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation11
Performance evaluation of the new hematology analyzer UniCel DxH 90011
How I investigate acquired megaloblastic anemia11
Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants10
Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay10
Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study10
Monocyte distribution width adds prognostic value in detection of COVID‐19 respiratory failure10
Recurrent PROC and novel PROS1 mutations in Vietnamese patients diagnosed with idiopathic deep venous thrombosis10
Are the DOAC plasma level thresholds appropriate for clinical decision‐making? A reappraisal using thrombin generation testing10
Evolving concepts of pathogenesis of heparin‐induced thrombocytopenia: Diagnostic and therapeutic implications10
Changes in peripheral blood cellular morphology as diagnostic markers for COVID‐19 infection10
Update on platelet procoagulant mechanisms in health and in bleeding disorders10
Is neutrophilia associated with mortality in COVID‐19 patients? A meta‐analysis and meta‐regression10
Laboratory approach to investigation of anemia in pregnancy9
Identification of acquired PIGA mutations and additional variants by next‐generation sequencing in paroxysmal nocturnal hemoglobinuria9
Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis9
Overall hemostasis potential and aPTT‐clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype9
A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network9
ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies9
International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser‐reagent test systems. Part 1: Instrument‐specific issues and commonly use9
Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera9
Trimester‐specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state9
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD—Comparison of four assay methods9
Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications9
Diagnostic value of white blood cell parameters for COVID‐19: Is there a role for HFLC and IG?9
Increased monocyte distribution width in COVID‐19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency9
TACC3 expression as a prognostic factor in aggressive types of adult T‐cell leukemia/lymphoma patients9
Plasma hemoglobin: A method comparison of six assays for hemoglobin and hemolysis index measurement9
New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data8
Major rise of a chronic lymphoid leukemia clone during the course of COVID‐198
Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia8
Circulating tumor DNA by high‐throughput sequencing of T cell receptor monitored treatment response and predicted treatment failure in T cell lymphomas8
Cell population data: Could a routine hematology analyzer aid in the differential diagnosis of COVID‐19?8
Identification of thalassemia gene cluster deletion by long‐read whole‐genome sequencing (LR‐WGS)8
Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat8
Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine8
Effects of circadian variation, lifestyle and environment on hematological parameters: A narrative review8
Study of in vitro thrombin generation after neutralization of heparin8
The characteristic peripheral blood morphological features of hospitalized patients infected with COVID‐198
The effect of DOAC‐Stop® on several oral and parenteral anticoagulants8
Harmonizing platelet function analyzer testing and reporting in a large laboratory network8
Reduced activity of B lymphocytes, recognised by Sysmex XN‐2000™ haematology analyser, predicts mortality in patients with coronavirus disease 20198
To B‐ or not to B‐: A review of lineage switched acute leukemia8
Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed8
Systematic review about etiologic association to the leukoerythroblastic reaction8
Evaluation of the accuracy of immature granulocyte percentage in predicting pediatric serious bacterial infection8
Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays8
COVID‐19 patient with immune thrombocytopenic purpura8
Pneumatic tube transport of blood samples affects global hemostasis and platelet function assays7
The integration of Sysmex XN‐9100’ WPC channel reflex testing in the detection of reactive versus malignant blood samples7
Application of an optimized interpretation model in capillary hemoglobin electrophoresis for newborn thalassemia screening7
The lncRNA SLCO4A1‐AS1/miR‐876‐3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway7
Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunity7
Detection and significance of green inclusions in peripheral blood neutrophils and monocytes7
Predicting bacteraemia in maternity patients using full blood count parameters: A supervised machine learning algorithm approach7
Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients7
Usefulness of automated fragmented red blood cell percentage in the diagnosis of paediatric haemolytic uraemic syndrome7
Thrombin generation abnormalities in Quebec platelet disorder7
Laboratory methods for monitoring argatroban in heparin‐induced thrombocytopenia7
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges7
How I investigate minimal residual disease in acute lymphoblastic leukemia7
CXCL2 benefits acute myeloid leukemia cells in hypoxia7
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy7
Screening on platelet LncRNA expression profile discloses novel residual platelet reactivity biomarker7
Development and exacerbation of autoimmune hemolytic anemia following COVID‐19 vaccination: A systematic review7
Erythropoiesis changes with increasing age in the elderly Chinese7
Immune thrombocytopenic purpura after COVID‐19 infection7
Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method7
Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience7
Distinguishing iron deficiency from beta‐thalassemia trait by new generation ektacytometry7
Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study7
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months7
Standardization and harmonization in hematology: Instrument alignment, quality control materials, and commutability issue7
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐197
Spectrum mutations of PRF1, UNC13D, STX11, and STXBP2 genes in Vietnamese patients with hemophagocytic lymphohistiocytosis6
Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID‐19—A common clinical feature between a rare disorder and a new, common infection6
Neutrophil‐to‐lymphocyte ratio is independently associated with COVID‐19 severity: An updated meta‐analysis based on adjusted effect estimates6
Parameters of the complete blood count predict in hospital mortality6
Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera6
Continuous reference curves for common hematology markers in the CALIPER cohort of healthy children and adolescents on the Sysmex XN‐3000 system6
Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants6
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations6
Transient increase in blast count following COVID‐19 infection mimicking acute leukemia6
Thrombin generation abnormalities in commonly encountered platelet function disorders6
Aiding clinical assessment of neonatal sepsis using hematological analyzer data with machine learning techniques6
Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia6
CaMKIIγ regulates the viability and self‐renewal of acute myeloid leukaemia stem‐like cells by the Alox5/NF‐κB pathway6
Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia6
High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID‐19 diagnosis?6
Downregulation of Lymphoid enhancer‐binding factor 1 (LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologi6
Impact of variation in reagent combinations for one‐stage clotting assay on assay discrepancy in nonsevere haemophilia A6
Evaluation of a new thromboplastin reagent STA‐NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels6
Rebuttal of a paper submitted by Hans‐Inge Bengtsson6
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID‐196
A study to compare Hematopoietic Progenitor Cell count determined on a next‐generation automated cell counter with flow cytometric CD34 count in peripheral blood and the harvested peripheral blood ste6
Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum6
Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia6
High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic synd6
Laboratory practices for manual blood film review: Results of an IQMH patterns of practice survey6
Cross‐evaluation of five slidemakers and three automated image analysis systems: The pitfalls of automation?6
Association of FOXP3 gene polymorphisms with chronic immune thrombocytopenia in a Chinese Han population6
Pitfalls in CALR exon 9 mutation detection: A single‐center experience in 571 positive patients6
Do congenital bleeding disorders have a protective effect against COVID‐19? A prospective study6
Brief communication: Distribution of bone marrow cell subsets and hemodilution in patients with acute leukemia6
Reduced expansion of CD94/NKG2C+ NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or 5
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials5
Biological variation data and analytical specification goal estimates of the thrombin generation assay with and without thrombomodulin in healthy individuals5
PCAT18, as a novel differentially regulated long noncoding RNA in adult acute myeloid leukemia patients revealed by next‐generation sequencing5
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients5
Reference intervals of white blood cell parameters for healthy adults in japan5
Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment5
Evaluation and comparison of the new Mindray BC‐6200 hematology analyzer with ADVIA 2120i5
Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer5
Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis5
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing5
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltra5
Evaluation of automated capillary complete blood counts for routine clinical decision making in a large cohort of hematological patients, using Mindray BC‐3000 Plus Auto and Sysmex XE‐5000 hematology 5
How I investigate dysgranulopoiesis5
The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm5
Circulating Hodgkin cells: A clinicopathologic analysis of seven patients and a review of the literature5
A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease5
Red cell distribution width and in‐hospital mortality in septic shock: A public database research5
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia5
Functional multigenic variations associated with hodgkin lymphoma5
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X5
Improvement of mortality prediction accuracy in critically ill patients through combination of SOFA and APACHE II score with markers of stress haematopoiesis5
Differences between capillary and venous blood counts in children—A data mining approach5
Early detection of Candida parapsilosis sepsis in peripheral blood as a result of cytografic changes on the Sysmex XN‐3000 hematology analyzer5
Comparative sequencing data analysis of Ion Torrent and MinION sequencing platforms using a clinical diagnostic haematology panel5
Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis5
A new approach for diagnosing hematological malignancies using monocytosis workflow optimization and abnormal lymphocyte/blast flag of Sysmex XN series of blood count analyzers5
IgE monoclonal gammopathy: The clinical relevance to perform the immunofixation using IgE antisera5
C‐reactive protein‐induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII5
Immature platelet fraction over time and clinical outcomes in patients with acute myocardial infarction5
Platelet count in sodium citrate‐anticoagulated whole blood: Comparison to EDTA‐anticoagulated results and stability over time5
Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study5
Limitations of a calibrated, quantitative APC‐R assay under routine conditions5
Schistocyte quantitation, thrombotic microangiopathy and acute kidney injury in Australian snakebite coagulopathy [ASP28]5
Establishing Ghanaian adult reference intervals for hematological parameters controlling for latent anemia and inflammation5
Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen5
Full spectrum flow cytometry in the clinical laboratory5
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia5
Persistent hiccups in a patient with mild congenital factor V deficiency and COVID‐19; clinical and laboratory finding of a rare bleeding disorder5
Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure5
Automated differential diagnosis method for iron deficiency anemia and beta thalassemia trait based on iterative Chi2 feature selector5
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates5
Standardization of reticulocyte counts in the athlete biological passport: A practical update5
Improving performance of recently introduced flow cytometry‐based approach of malignant cell screening in serous cavity effusion4
Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients4
Falsely decreased FVIII activity following pneumatic tube transport4
MicroRNAs in urine as diagnostic biomarkers for multiple myeloma4
Alterations in leucocyte cell population data in bacteraemia: A study from a tertiary care hospital in India4
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors4
Routine haematology parameters in COVID‐19 patients and clinical outcome: A Belgian single‐centre study4
Characterization and identification of Prachinburi β0‐thalassemia: A novel‐60 kb deletion in beta globin gene related to high levels of Hb F in heterozygous state4
Differential diagnosis of thalassemia and iron deficiency anemia using the CellaVision Advanced Red Blood Cell software4
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform4
Viscoelastic testing: Critical appraisal of new methodologies and current literature4
Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+4
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays4
Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital4
Epigenetic analysis reveals significant differential expression of miR‐378C and miR‐128‐2‐5p in a cohort of relapsed pediatric B‐acute lymphoblastic leukemia cases4
Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods4
A stepwise haematological screening and whole‐exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A2 from a cohort of 47336 indivi4
Analysis of laboratory blood parameter results for patients diagnosed with COVID‐19, from all ethnic group populations: A single centre study4
Reference intervals of automated reticulocyte count and immature reticulocyte fraction in a pediatric population4
Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next‐Generation Sequencing are associated with disease progression in a North American Adult T‐Cell Leukemia/Lympho4
The role of cystatin C in multiple myeloma4
Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study4
Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia4
Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia4
A comparative evaluation of the CN‐6000 haemostasis analyser using coagulation, amidolytic, immuno‐turbidometric and light transmission aggregometry assays4
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing4
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy4
Applied machine learning in hematopathology4